4 Results for "

CRL4CRBN ubiquitin-proteasome system

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CRL4CRBN ubiquitin-proteasome system" in MCE Product Catalog:

Cat. No.: HY-134983
CAS No.: 2222114-22-7
Purity:  96.47%
Thalidomide-piperazine hydrochloride is a synthetic E3 ligase ligand-linker conjugate, containing a cereblon ligand based on Thalidomide (HY-14658) and one linker. Thalidomide-piperazine hydrochloride can be used in studies related to PROTAC synthesis .
loading...
    loading...
Cat. No.: HY-177694
CAS No.: 2798907-41-0
Research Areas:  

Cancer

PROTAC AR Degrader-11 is a PROTAC degrader that targets the androgen receptor (AR) and its splice variant AR-V7. PROTAC AR Degrader-11 simultaneously degrades full-length AR and AR-V7 via the ubiquitin-proteasome system by recruiting the CRL4-CRBN E3 ligase (FIG.2A). PROTAC AR Degrader-11 reduces the viability of cancer cells. PROTAC AR Degrader-11 can be used in studies related to castration-resistant prostate cancer .
loading...
    loading...
Cat. No.: HY-184913
Target:  

PROTACs CDK

Research Areas:  

Cancer

JHK-02-102-1 is a selective CDK5 degrader derived from the regorafenib kinase inhibitor scaffold. JHK-02-102-1 recruits CRL4CRBN E3 ubiquitin ligase to induce ternary complex formation between CDK5 and CRBN, triggering ubiquitin-proteasome system-dependent degradation. JHK-02-102-1 achieves selectivity redirection from CDK6 to CDK5 via subtle PROTAC architecture modifications .
loading...
    loading...
Cat. No.: HY-177728
CAS No.: 2413733-73-8
Research Areas:  

Cancer

MG degrader 3 is a molecular glue degrader that induces the degradation of multiple proteins including GSPT1, ZFP91 and CK1α via the ubiquitin-proteasome system, regulates protein stability and cellular signaling networks, and exhibits anti-proliferative activity against multiple myeloma cells. MG degrader 3 can be applied in the research of multiple myeloma .
loading...
    loading...